Tag: Huntsman Corp

  • Investor’s Alert: Southwest Airlines Co (NYSE:LUV), Huntsman Corporation (NYSE:HUN), AbbVie Inc (NYSE:ABBV), ConocoPhillips (NYSE:COP), Cadence Design Systems Inc (NASDAQ:CDNS)

    Southwest Airlines Co (NYSE:LUV) reported $0.18 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.17 by $0.01. The company had revenue of $4.17 billion for the quarter, compared to the consensus estimate of $4.17 billion. During the same quarter in the prior year, the company posted $0.07 earnings per share. The company’s quarterly revenue was up 2.0% on a year-over-year basis. Southwest Airlines Co (NYSE:LUV) net profit margin is 4.80% and weekly performance is 4.79%. On last trading day company shares ended up $25.79. Analysts mean target price for the company is $27.21. Southwest Airlines Co (NYSE:LUV) distance from 50-day simple moving average (SMA50) is 7.59%.

    On May 12, at the Annual Meeting of Stockholders of Huntsman Corporation (NYSE:HUN) approved an amendment and restatement to the Huntsman Stock Incentive Plan in order to, among other items, increase the number of shares reserved for issuance under the plan by 4,580,000 shares and maintain the plan’s compliance with Section 162(m) of the Internal Revenue Code of 1986, as amended. Huntsman Corporation (NYSE:HUN) shares advanced 2.60% in last trading session and ended the day on $26.88. HUN Gross Margin is 16.70% and its return on assets is 2.30%. Huntsman Corporation (NYSE:HUN) quarterly performance is 14.87%.

    On 22 MAY AbbVie Inc (NYSE:ABBV) develops and commercializes a wide range of advanced treatments for adults and children. AbbVie Inc (NYSE:ABBV)’s experimental drug that just got special attention from the reviewers is known as elotuzumab. The drug targets multiple myeloma, one of the most common forms of blood cancer. The drug showed compelling results in its midstage trial when used in a combination of other treatments. AbbVie Inc (NYSE:ABBV) shares moved up 0.60% in last trading session and was closed at $53.95, while trading in range of $53.83 – $54.38. AbbVie Inc (NYSE:ABBV) year to date (YTD) performance is 3.89%.

    ConocoPhillips (NYSE:COP) reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.56 by $0.25. During the same quarter in the previous year, the company posted $1.42 earnings per share. On average, analysts predict that ConocoPhillips will post $6.31 earnings per share for the current fiscal year. ConocoPhillips (NYSE:COP) ended the last trading day at $78.43. Company weekly volatility is calculated as 0.74% and price to cash ratio as 14.77. ConocoPhillips (NYSE:COP) showed a positive weekly performance of 1.37%.

    Cadence Design Systems Inc (NASDAQ:CDNS) reported $0.20 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.19 by $0.01. The company had revenue of $378.55 million for the quarter, compared to the consensus estimate of $376.80 million. During the same quarter last year, the company posted $0.21 earnings per share. Cadence Design Systems’s revenue was up 6.9% compared to the same quarter last year. Cadence Design Systems Inc (NASDAQ:CDNS) net profit margin is 8.00% and weekly performance is 7.90%. On last trading day company shares ended up $16.94. Analysts mean target price for the company is $18.00. Cadence Design Systems Inc (NASDAQ:CDNS) distance from 50-day simple moving average (SMA50) is 10.19%.